WO2004024120A3 - Medicated skin cleansing products comprising an antimycotic agent - Google Patents
Medicated skin cleansing products comprising an antimycotic agent Download PDFInfo
- Publication number
- WO2004024120A3 WO2004024120A3 PCT/IL2003/000738 IL0300738W WO2004024120A3 WO 2004024120 A3 WO2004024120 A3 WO 2004024120A3 IL 0300738 W IL0300738 W IL 0300738W WO 2004024120 A3 WO2004024120 A3 WO 2004024120A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antimycotic agent
- skin cleansing
- cleansing products
- medicated skin
- medicated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003259539A AU2003259539A1 (en) | 2002-09-11 | 2003-09-08 | Medicated skin cleansing products comprising an antimycotic agent |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL151686 | 2002-09-11 | ||
IL15168602A IL151686A0 (en) | 2002-09-11 | 2002-09-11 | Medicated skin cleansing products |
IL157585 | 2003-08-26 | ||
IL15758503A IL157585A0 (en) | 2003-08-26 | 2003-08-26 | Medicated skin cleansing products |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2004024120A2 WO2004024120A2 (en) | 2004-03-25 |
WO2004024120A3 true WO2004024120A3 (en) | 2004-06-24 |
WO2004024120B1 WO2004024120B1 (en) | 2004-07-29 |
Family
ID=31995792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2003/000738 WO2004024120A2 (en) | 2002-09-11 | 2003-09-08 | Medicated skin cleansing products comprising an antimycotic agent |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003259539A1 (en) |
WO (1) | WO2004024120A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20061770A1 (en) * | 2006-09-18 | 2008-03-19 | Carlo Ghisalberti | COSMETIC METHOD OF REDUCING EYES |
CN103893176B (en) * | 2014-04-03 | 2016-08-17 | 济川药业集团有限公司 | A kind of treat itching of the scalp and medicine that dandruff increases |
DE102019210158A1 (en) * | 2019-07-10 | 2021-01-14 | Henkel Ag & Co. Kgaa | Solid cosmetic detergents |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996029983A1 (en) * | 1995-03-31 | 1996-10-03 | Colgate-Palmolive Company | Skin care products containing anti-itching/anti-irritant agents |
US5989536A (en) * | 1993-07-03 | 1999-11-23 | The Procter & Gamble Company | Personal cleansing compositions containing alkoxylated ether and cationic ammonium salt for deposition of active agent upon the skin |
GB2342862A (en) * | 1998-10-23 | 2000-04-26 | Johannes Marthinus Snyman | Solid cleansing soap bar containing an antifungal agent for treatment of mycotic skin disorders such as candida |
WO2002017876A2 (en) * | 2000-08-31 | 2002-03-07 | Unilever Plc | Foaming anti-bacterial cleansing skin product |
-
2003
- 2003-09-08 AU AU2003259539A patent/AU2003259539A1/en not_active Abandoned
- 2003-09-08 WO PCT/IL2003/000738 patent/WO2004024120A2/en active Search and Examination
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5989536A (en) * | 1993-07-03 | 1999-11-23 | The Procter & Gamble Company | Personal cleansing compositions containing alkoxylated ether and cationic ammonium salt for deposition of active agent upon the skin |
WO1996029983A1 (en) * | 1995-03-31 | 1996-10-03 | Colgate-Palmolive Company | Skin care products containing anti-itching/anti-irritant agents |
GB2342862A (en) * | 1998-10-23 | 2000-04-26 | Johannes Marthinus Snyman | Solid cleansing soap bar containing an antifungal agent for treatment of mycotic skin disorders such as candida |
WO2002017876A2 (en) * | 2000-08-31 | 2002-03-07 | Unilever Plc | Foaming anti-bacterial cleansing skin product |
Also Published As
Publication number | Publication date |
---|---|
WO2004024120B1 (en) | 2004-07-29 |
AU2003259539A1 (en) | 2004-04-30 |
AU2003259539A8 (en) | 2004-04-30 |
WO2004024120A2 (en) | 2004-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001027119A3 (en) | Substance library containing bicyclic imidazo-5-yl-amines and/or bicyclic imidazo-3-yl-amines | |
IL157652A (en) | Metalloproteinase inhibitors, compositions comprising them and uses thereof for the preparation of medicaments for treating diseases or conditions mediated by metalloproteinase enzymes | |
HUP0402629A3 (en) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
AU2003226014A1 (en) | Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic lateral sclerosis and alzheimer's disease | |
HUP0600332A2 (en) | Aerosolized decongestants for the treatment of sinusitis | |
EP1562897A4 (en) | Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer s disease | |
HUP0402150A3 (en) | 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1-antagonistic activity, process for the preparation, pharmaceutical compositions containing them and their use for production of pharmaceutical compositions | |
IL144643A0 (en) | Jak-3 inhibitors for treating allergic disorders | |
GB0223040D0 (en) | Therapeutic compounds | |
WO2002092122A3 (en) | Use of osteopontin for the treatment and/or prevention of neurologic diseases | |
HUP0401605A3 (en) | Integrin inhibitors for the treatment of eye diseases | |
WO1997011666A3 (en) | Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases | |
WO2004082706A3 (en) | Ifn-beta alone or in combination with other medicaments for treating alzheimer's disease and demens disorders | |
WO2005035674A3 (en) | Product comprising a fibrous support and a hydrophilic and/or permeabilizing coating, preparation method thereof and use of same | |
MXPA03009984A (en) | Preparation for the removal of abnormal keratin material. | |
WO2002039997A3 (en) | Ace-2 modulating compounds and use thereof | |
EP1406648A4 (en) | The use of angiotensin i derivative as an agent for the treatment and prevention of infarction-related cardiac injuries and disorders | |
HK1062810A1 (en) | Use of il-18 inhibitors for the manufacture of medicaments for treatment and/or prevention of heartdisease | |
WO2004024120A3 (en) | Medicated skin cleansing products comprising an antimycotic agent | |
EP0870502A3 (en) | Use of adenosine uptake inhibitors for the manufacture of a medicament for the treatment of pancreatitis | |
CA2183234A1 (en) | Agent for prophylaxis and treatment of thromboxane a2-mediated diseases | |
AU2182800A (en) | Use of inhibitors of gag synthesis for the treatment of corneal haze | |
AU2003260935A1 (en) | Medicated skin cleansing products comprising an antimycotic agent | |
WO2003059395A3 (en) | Antisense compounds directed against human csf-1 | |
WO2003000269A3 (en) | Novel use for pde 10a inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
B | Later publication of amended claims |
Effective date: 20040615 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) |